Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1987 Aug;58(2):96–100. doi: 10.1136/hrt.58.2.96

Atrial natriuretic peptide in spontaneous tachycardias.

I G Crozier, H Ikram, M G Nicholls, E A Espiner, T G Yandle
PMCID: PMC1277286  PMID: 2956981

Abstract

Because anecdotal reports suggest that concentrations of atrial natriuretic peptide are raised during tachycardias, plasma immunoreactive atrial natriuretic peptide concentrations were measured in 34 consecutive patients when tachycardia was diagnosed and again five and 15 minutes after conversion to sinus rhythm. Plasma atrial natriuretic peptide concentrations were raised in all but four patients, and were higher in patients with known heart disease than in those without. The concentrations were higher with ventricular tachycardia than with atrial fibrillation or supraventricular tachycardia, and in acute versus chronic tachycardia. There was only a weak positive relation between ventricular rate and atrial natriuretic peptide (r = 0.31); but there was a closer inverse correlation between atrial natriuretic peptide and systolic arterial pressure (r = -0.60). Conversion to sinus rhythm was associated with a definite fall in plasma atrial natriuretic peptide concentrations. Despite very high baseline concentrations of atrial natriuretic peptide only two patients reported polyuria. It is likely that atrial pressure rather than ventricular rate determines atrial natriuretic peptide release during tachycardia. Despite the absence of polyuria in all but two patients in this study atrial peptides could still contribute to, or cause, the polyuria of tachycardias.

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alicandri C., Fouad F. M., Tarazi R. C., Castle L., Morant V. Three cases of hypotension and syncope with ventricular pacing: possible role of atrial reflexes. Am J Cardiol. 1978 Jul;42(1):137–142. doi: 10.1016/0002-9149(78)90998-0. [DOI] [PubMed] [Google Scholar]
  2. Anderson J. V., Gibbs J. S., Woodruff P. W., Greco C., Rowland E., Bloom S. R. The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. J Hypertens Suppl. 1986 Jun;4(2):S137–S141. [PubMed] [Google Scholar]
  3. Biollaz J., Nussberger J., Waeber B., Brunner H. R. Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide. J Hypertens Suppl. 1986 Jun;4(2):S101–S108. [PubMed] [Google Scholar]
  4. Blaine E. H., Heinel L. A., Schorn T. W., Marsh E. A., Whinnery M. A. The character of the atrial natriuretic response: pressure and volume effects. J Hypertens Suppl. 1986 Jun;4(2):S17–S24. [PubMed] [Google Scholar]
  5. Crozier I. G., Nicholls M. G., Ikram H., Espiner E. A., Gomez H. J., Warner N. J. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet. 1986 Nov 29;2(8518):1242–1245. doi: 10.1016/s0140-6736(86)92675-9. [DOI] [PubMed] [Google Scholar]
  6. Cuneo R. C., Espiner E. A., Nicholls M. G., Yandle T. G., Joyce S. L., Gilchrist N. L. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. J Clin Endocrinol Metab. 1986 Oct;63(4):946–953. doi: 10.1210/jcem-63-4-946. [DOI] [PubMed] [Google Scholar]
  7. Dietz J. R. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am J Physiol. 1984 Dec;247(6 Pt 2):R1093–R1096. doi: 10.1152/ajpregu.1984.247.6.R1093. [DOI] [PubMed] [Google Scholar]
  8. Erlebacher J. A., Danner R. L., Stelzer P. E. Hypotension with ventricular pacing: an atria vasodepressor reflex in human beings. J Am Coll Cardiol. 1984 Sep;4(3):550–555. doi: 10.1016/s0735-1097(84)80100-x. [DOI] [PubMed] [Google Scholar]
  9. Folsom A. R., Smith C. L., Prineas R. J., Grimm R. H., Jr Serum calcium fractions in essential hypertensive and matched normotensive subjects. Hypertension. 1986 Jan;8(1):11–15. doi: 10.1161/01.hyp.8.1.11. [DOI] [PubMed] [Google Scholar]
  10. KISCH B. Electron microscopy of the atrium of the heart. I. Guinea pig. Exp Med Surg. 1956;14(2-3):99–112. [PubMed] [Google Scholar]
  11. Kangawa K., Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun. 1984 Jan 13;118(1):131–139. doi: 10.1016/0006-291x(84)91077-5. [DOI] [PubMed] [Google Scholar]
  12. Ledsome J. R., Wilson N., Courneya C. A., Rankin A. J. Release of atrial natriuretic peptide by atrial distension. Can J Physiol Pharmacol. 1985 Jun;63(6):739–742. doi: 10.1139/y85-121. [DOI] [PubMed] [Google Scholar]
  13. Luria M. H., Adelson E. I., Lochaya S. Paroxysmal tachycardia with polyuria. Ann Intern Med. 1966 Sep;65(3):461–470. doi: 10.7326/0003-4819-65-3-461. [DOI] [PubMed] [Google Scholar]
  14. Richards A. M., Cleland J. G., Tonolo G., McIntyre G. D., Leckie B. J., Dargie H. J., Ball S. G., Robertson J. I. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):409–412. doi: 10.1136/bmj.293.6544.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Richards A. M., Nicholls M. G., Espiner E. A., Ikram H., Yandle T. G., Joyce S. L., Cullens M. M. Effects of alpha-human atrial natriuretic peptide in essential hypertension. Hypertension. 1985 Sep-Oct;7(5):812–817. doi: 10.1161/01.hyp.7.5.812. [DOI] [PubMed] [Google Scholar]
  16. Richards A. M., Nicholls M. G., Ikram H., Webster M. W., Yandle T. G., Espiner E. A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. doi: 10.1016/s0140-6736(85)91207-3. [DOI] [PubMed] [Google Scholar]
  17. Samet P., Bernstein W. H., Levine S., Lopez A. Hemodynamic effects of tachycardias produced by atrial and ventricular pacing. Am J Med. 1965 Dec;39(6):905–910. doi: 10.1016/0002-9343(65)90112-9. [DOI] [PubMed] [Google Scholar]
  18. Schiffrin E. L., Gutkowska J., Kuchel O., Cantin M., Genest J. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med. 1985 May 2;312(18):1196–1197. doi: 10.1056/NEJM198505023121822. [DOI] [PubMed] [Google Scholar]
  19. Schlepper M., Weppner H. G., Merle H. Haemodynamic effects of supraventricular tachycardias and their alterations by electrically and verapamil induced termination. Cardiovasc Res. 1978 Jan;12(1):28–33. doi: 10.1093/cvr/12.1.28. [DOI] [PubMed] [Google Scholar]
  20. Sosa R. E., Volpe M., Marion D. N., Atlas S. A., Laragh J. H., Vaughan E. D., Jr, Maack T. Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Physiol. 1986 Mar;250(3 Pt 2):F520–F524. doi: 10.1152/ajprenal.1986.250.3.F520. [DOI] [PubMed] [Google Scholar]
  21. Tikkanen I., Fyhrquist F., Metsärinne K., Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet. 1985 Jul 13;2(8446):66–69. doi: 10.1016/s0140-6736(85)90178-3. [DOI] [PubMed] [Google Scholar]
  22. Tikkanen I., Metsärinne K., Fyhrquist F. Atrial natriuretic peptide in paroxysmal supraventricular tachycardia. Lancet. 1985 Jul 6;2(8445):40–41. doi: 10.1016/s0140-6736(85)90087-x. [DOI] [PubMed] [Google Scholar]
  23. WOOD P. Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation. Br Heart J. 1963 May;25:273–282. doi: 10.1136/hrt.25.3.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yamaji T., Ishibashi M., Nakaoka H., Imataka K., Amano M., Fujii J. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias. Lancet. 1985 May 25;1(8439):1211–1211. doi: 10.1016/s0140-6736(85)92883-1. [DOI] [PubMed] [Google Scholar]
  25. Yandle T. G., Espiner E. A., Nicholls M. G., Duff H. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J Clin Endocrinol Metab. 1986 Jul;63(1):72–79. doi: 10.1210/jcem-63-1-72. [DOI] [PubMed] [Google Scholar]
  26. Yandle T. G., Richards A. M., Nicholls M. G., Cuneo R., Espiner E. A., Livesey J. H. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci. 1986 May 19;38(20):1827–1833. doi: 10.1016/0024-3205(86)90137-2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES